Skip to content

A prospective AI study based on T staging platform of panoramic large-section rectal cancer

A prospective AI study based on T staging platform of panoramic large-section rectal cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029489
Enrollment
Unknown
Registered
2020-02-02
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

Gold Standard:pathological diagnosis
Index test:the&#32
panoramic&#32
cancer&#32
imaging&#32
of&#32
system

Sponsors

Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Rectal cancer patients aged 40-70 years; 2. The patient has received high-resolution MRI; 3. The patient was treated for the first time without surgery, radiotherapy or chemotherapy; 4. signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Combined with diabetes mellitus, rheumatic immune diseases, severe heart, brain, kidney and other systemic diseases; 2. The imaging confirmed the presence of pelvic organ abnormality; 3. other pelvic surgery was performed; 4. Patients who have undergone chemoradiotherapy or secondary surgery.

Design outcomes

Primary

MeasureTime frame
Tumor location;Pathological type of tumor;Tumor T stage;Relationship between tumor and surrounding tissue;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactLu Yun

Affiliated Hospital of Qingdao University

cloudylucn@126.com+86 18661802231

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026